Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.

Specifically, three blinded, unaffiliated readers assigned fewer FP ratings with the reduced dose of gadobenate, which resulted in small, but highly significant benefit in specificity for lesion characterization, without a loss of sensitivity for lesion detection.

also in 132,142 other papers